Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Interferon-alpha and ribavirin therapy on chronic hepatitis C virus infection: the experience of Rio Grande do Sul State Health Department, Brazil].

Arquivos de gastroenterologia - 1 Jan 2000

Alves Alexandro Vaesken, de Azevedo Andrea Prates da Cunha, Perin Chistiano, Ramos Gabriel Zatti, Brandão Ajacio Bandeira de Mello, de Mattos Angelo Alves, de Almeida Paulo Roberto Leiria

Abstract excerpt

BACKGROUND: Chronic infection by hepatitis C virus is an important public health issue. AIMS: To assess the effectiveness of a combination therapy with interferon-alpha plus ribavirin and to identify predictive factors of response in adult patients with chronic hepatitis C in a public drug supply program. PATIENTS AND METHODS: A retrospective study of consecutive records of 400 patients with chronic hepatitis C...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Predictive Value of Tests

Share to Ribavirin

Share to Treatment Outcome

Source

Identifiers

PMID: 15264044
DOI: 10.1590/s0004-28032003000400006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Interferon-alpha and ribavirin therapy on chronic hepatitis C virus infection: the experience of Rio Grande do Sul State Health Department, Brazil].PMID 15264044Read ↗

[The sustained response rates for chronic hepatitis C patients undergoing therapy with the several interferons and ribavarins supplied by Brazilians Health Ministry is comparable to those reported in the literature].Semantic proximity Read ↗

[Efficacy of combination treatment with pegylated interferon plus ribavirin in patients chronically infected with HCV].Semantic proximity Read ↗

Treatment of hepatitis C with peginterferon and ribavirin in a public health program.Semantic proximity Read ↗

Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil.Semantic proximity Read ↗

The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study.Semantic proximity Read ↗

Outcome of antiviral treatment in patients with chronic genotype 1 HCV hepatitis. A retrospective study in 507 patients.Semantic proximity Read ↗

The effectiveness of retreatment with peginterferon alfa and ribavirin in patients with chronic viral hepatitis C genotype 2 and 3: a prospective cohort study in Brazil.Semantic proximity Read ↗

[Treatment of chronic hepatitis viral C: new associations].Semantic proximity Read ↗

National Brazilian survey on the outcomes of hepatitis c retreatment in patients non-responders to direct antiviral agents.Semantic proximity Read ↗

Therapy of chronic hepatitis C: a critical review.Semantic proximity Read ↗

[Alpha-interferon versus peg-interferon associated to ribavirin in the treatment of genotype 1 hepatitis C virus and human immunodeficiency virus coinfected patients].Semantic proximity Read ↗

Effectiveness of first-wave protease inhibitors in hepatitis C virus genotype 1 infection: a multicenter study in Brazil.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.